Compare Southern Copper Corp (SCCO) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Southern Copper Corp vs Zoetis Inc — how do they compare? Southern Copper Corp trades at $196.05 (market cap $176.69B), while Zoetis Inc trades at $73.83 (market cap $30.29B). The key difference: Southern Copper Corp is far larger — about 5.8× Zoetis Inc's market cap, and Zoetis Inc pays the higher dividend (2.89%). Which is the better fit depends on your goals.
| SCCO | ZTS | |
|---|---|---|
Market Cap | $176.69B | $30.29B |
Sector | Basic Materials | Health |
52-Week High | $219.70 | $150.61 |
52-Week Low | $102.10 | $71.91 |
Enterprise Value | $177.98B | $37.86B |
Dividend Yield | 2.1% | 2.89% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Southern Copper (SCCO) trades at $208.56, up 4.93% in the last 24 hours, with a bullish technical signal from moving averages and strong support near $205. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $1.99 exceeding expectations, and demonstrates high profitability with a net margin of 35.87% and ROE of 50.07%. Revenue growth is accelerating, reaching $13.42B in 2025, supported by rising copper prices and a $20.5B investment plan for production expansion.
The outlook for SCCO is positive due to strong copper demand from AI infrastructure and trade policy shifts, but risks include premium valuations (P/E of 31.29) and lower H1 2026 copper output. Analyst sentiment is mixed with a consensus price target of $154.58, below the current price, indicating caution despite institutional buying interest from firms like BlackRock and Bank of New York Mellon.
Zoetis (ZTS) trades at $73.6, down 2.92% on the day, near its 52-week low amid bearish technical signals. The stock shows strong fundamentals with a P/E of 12, net margin of 27.69%, and consistent earnings beats, but faces headwinds from weak U.S. companion animal sales and reduced 2026 guidance. Recent news includes an FDA emergency use authorization for Simparica Trio and participation in healthcare conferences.
The outlook is mixed: valuation appears attractive with a consensus price target of $93.40, but near-term risks include competitive pressures and soft pet health demand. Long-term investors may find value in its profitability and market dominance, though volatility persists from sector challenges and investor sentiment shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Southern Copper Corp
Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. Southern Copper generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. Its geographical segments are The Americas, Europe, and Asia.
Read more on SCCO →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
